MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

485029

Report Date :

09.01.2018

 

IDENTIFICATION DETAILS

 

Name :

GLOCHEM INDUSTRIES PRIVATE LIMITED (w.e.f. 07.07.2017)  

 

 

Formerly known as :

GLOCHEM INDUSTRIES LIMITED

 

 

Registered Office :

G.V. Chambers 7-2-C8 and C8/2, Sanata Nagar, Hyderabad – 500018, Telangana

Mobile No.:

91-9849847907 (Mr. Madipalli Gopala Krishna)

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

20.11.1995

 

 

Com. Reg. No.:

36-022303

 

 

Capital Investment / Paid-up Capital :

INR 27.401 Million

 

 

CIN No.:

[Company Identification No.]

U24110TG1995PTC022303

 

 

IEC No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

GSTIN :

Not Divulged

 

 

PAN No.:

[Permanent Account No.]

AAACG9134E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in the business of manufacturing and marketing of Active Pharma Ingredients (APIs), drug intermediates, finished dosage forms (FDF) and contract manufacturing of FDF. (Registered activity)

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 2600000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company incorporated in the year 1995 and it is having fine track.

 

GIL is engaged into manufacturing of Active Pharmaceutical Ingredients (API’s), drug intermediaries, fine chemicals and undertakes contract manufacturing of APIs and intermediates for various global and local players.

 

Management of the company has not filed its financials of 2017 with government department.

 

For the financial year 2016, the company has increased its revenue from operation as compared to previous year and maintained healthy profitability margin of 10.75%.

 

Rating takes into consideration sound financial profile of the company marked by healthy networth base and low debt balance sheet.

 

Further, rating also reflects from its experienced of management, long track record of operations with presence in various regulated markets stable industry growth prospects and improvement in the revenue as well as profitability profile during the year.

 

However, rating strength is partially offset by forex risk on account of exports and regulatory challenges have been an integral part of the pharma industry.

 

Trade relations are reported as fair. Business is active. Payments terms are reported to be regular.

 

In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Fund Base CC Limit = BBB+

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

12.12.2017

 

Rating Agency Name

CARE

Rating

Short Term Rating = A2

Rating Explanation

Strong degree of safety and low credit risk.

Date

12.12.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 09.01.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED BY

 

Name :

Mr. Madipalli Gopala Krishna

Designation :

General Manager

Contact No.:

91-9849847907

Date :

08.01.2018

 

 

LOCATIONS

 

Registered Office / Corporate Office:

G.V. Chambers 7-2-C8 and C8/2, Sanata Nagar, Hyderabad – 500018, Telangana, India

Tel. No.:

91-40-39219900

Mobile No.:

91-9849847907 (Mr. Madipalli Gopala Krishna)

Fax No.:

91-40-23711483 /23813850

E-Mail :

kk@glochemindia.com

secretarial@globchemindia.com

careers@glochemindia.com

corporate@glochemindia.com

accounts@glochemindia.com

purchase@glochemindia.com

marketing@glochemindia.com

md@glochemindia.com

Website :

http://www.glochemindia.com

 

 

Unit-I, Bollaram, Hyderabad:

Survey No. 174-176, IDA Bollaram, Medak (District) - 502325, Telangana State, India.

Tel. No.:

91- 8452+302945 / 46

Fax No.:

91-8458-279058

E-Mail :

bollaram@glochemindia.com

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Vikram Ravindra Mamidipudi

Designation :

Director

Address :

Plot No.16, Card Master Road Arihant Road, Tarbund, Secunderabad – 500009, Telangana, India

Date of Birth/Age :

18.05.1956

Qualification :

B.Sc, FCA, LLB

Date of Appointment :

24.03.1999

DIN No.:

00008241

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

L18101TG1962PLC054323

GTN INDUSTRIES LIMITED

17/12/2005

-

L65191RJ1943PLC000135

THE BANK OF RAJASTHAN LIMITED

14/12/2009

-

L85110KA1992PLC013421

ASM TECHNOLOGIES LIMITED

30/06/1998

-

U24232TG2013PLC085349

EVERTOGEN LIFE SCIENCES LIMITED

27/03/2015

-

U24239TG2005PTC047102

AHLADA ENGINEERS PRIVATE LIMITED

27/09/2013

-

U51398TG1987PTC007885

NORMAK FASHIONS PRIVATE LIMITED

18/11/1988

-

U51909TG1981PLC041292

GTN ENGINEERING(INDIA) LIMITED

04/07/2014

-

U65922DL1996PLC249927

VENTURE FINANCE & DEVELOPMENT CORPORATION LIMITED.

28/09/2012

-

U67190KA2017PTC099319

ANA ARC PRIVATE LIMITED

26/09/2017

-

 

 

Name :

Mr. Mohanakrishna Reddy Arvabumi

Designation :

Director

Address :

8-2-293/82/W/78, New No-123, Road No-5, Womens Cop House Society, Jubilihills, Hyderabad – 500034, Telangana, India

Date of Birth/Age :

03.05.1956

Qualification :

MBA, MA

Date of Appointment :

24.12.2003

DIN No.:

00093185

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

L74210TG1987PLC007580

ALPHAGEO (INDIA) LIMITED

26/09/2014

-

U01122TG2004PTC042837

SRESTA NATURAL BIOPRODUCTS PRIVATE LIMITED

30/08/2013

-

U15499TG1994PTC019102

SYNTHOKEM LABS PRIVATE LIMITED

30/09/2016

-

U24110AP2005PTC047056

SAPALA ORGANICS PRIVATE LIMITED

30/09/2016

-

U45201TG1997PLC028680

GVPR ENGINEERS LIMITED

18/09/2015

-

U67120TG2005PTC047688

BANYAN SECURITIES AND FINANCIAL SERVICES PRIVATE LIMITED

01/10/2017

-

U72501TG2017PTC116600

CYIENT SOLUTIONS AND SYSTEMS PRIVATE LIMITED

19/04/2017

-

U74140TG1992PTC014155

M.ANANDAM CONSULTANCY SERVICES PRIVATE LIMITED

01/01/2005

-

U93090TN1962PTC004947

CHETTINAD CEMENT CORPORATION PRIVATE LIMITED

27/08/2014

-

 

 

Name :

Mr. Subbarao Kattamuri

Designation :

Managing Director

Address :

Plot No : 48, Nava Nirman Nagar, Road No.71, Jubilee Hills, Hyderabad – 500033, Telangana, India

Date of Birth/Age :

10.03.1953

Qualification :

B.Com FCA

Date of Appointment :

01.07.2011

PAN No.:

AEDPK4078F

DIN No.:

00107121

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U01119TG2010PTC069551

GIL AGROTECH ( INDIA ) PRIVATE LIMITED

20/07/2010

-

U24232TG2013PLC085349

EVERTOGEN LIFE SCIENCES LIMITED

09/02/2013

-

U24239AP2002PTC038417

K.R.R. DRUGS & INTERMEDIATES PRIVATE LIMITED

30/09/2015

-

U74999TG2016PTC112294

PRICHE GENERICS PRIVATE LIMITED

04/10/2016

-

U74999TG2017PTC120942

LYTICA LABS PRIVATE LIMITED

01/12/2017

-

 

 

Name :

Mr. Hazarath Basha Shaik

Designation :

Wholetime Director

Address :

Mastana Mahal, 22-307/7A, Phase –II, Opposite KPHB, Bhagya Nagar Colony, Near Sivaparvathi Theatre, Kukatpally, Hyderabad – 500072, Telangana, India

Date of Birth/Age :

23.03.1956

Qualification :

M.Tech

Date of Appointment :

01.07.2011

PAN No.:

AFVPS5026G

DIN No.:

01321868

 

 

Name :

Mr. Sundeep Kattamuri

Designation :

Wholetime Director

Address :

Plot No.48,Navanirman Nagar, Jubilee Hills, Road No.71, Hyderabad – 500033, Telangana, India

Date of Birth/Age :

17.11.1983

Qualification :

MS

Date of Appointment :

05.09.2011

PAN No.:

BRMPK2131G

DIN No.:

03128742

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24232TG2013PLC085349

EVERTOGEN LIFE SCIENCES LIMITED

13/02/2015

-

U24239AP2002PTC038417

K.R.R. DRUGS & INTERMEDIATES PRIVATE LIMITED

30/09/2015

-

U74999TG2016PTC112294

PRICHE GENERICS PRIVATE LIMITED

04/10/2016

-

U74999TG2017PTC120942

LYTICA LABS PRIVATE LIMITED

01/12/2017

-

 

 

KEY EXECUTIVES

 

Name :

Mr. Madipalli Gopala Krishna

Designation :

General Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2016 

 

SHAREHOLDERS DETAILS FILE ATTACHED

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2016

 

Category

Percentage

Promoter – (Individual/ Hindu Undivided Family – Indian)

52.70

Public  – (Individual/ Hindu Undivided Family – Indian)

22.25

Public - Bodies corporate

25.05

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the business of manufacturing and marketing of Active Pharma Ingredients (APIs), drug intermediates, finished dosage forms (FDF) and contract manufacturing of FDF. (Registered activity)

 

 

Products :

Item Code No.

Product Description

98041000 / 29333919

Amlodipine Besilate

29335990

Cetrizine DI HCl (BP/EP)

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

Punjab National Bank (on behalf of Consortium of PNB and Axis Bank Limited)

Branch

Hi-Tech City Branch, 1Q4-A3, 1st Floor, Cyber Tower, Madhapur, Hyderabad – 500081, Telangana, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

Secured Loan

31.03.2016

(INR in Million)

31.03.2015

(INR in Million)

Long-term Borrowings

 

 

Rupee term loans from banks

24.228

81.341

(The term loans are further secured by personal guarantee of Managing Director and also by a director of the company, to the extent of amount outstanding)

 

 

 

 

 

Short-term borrowings

 

 

Loans repayable on demand

232.329

234.634

(The loans are further secured by personal guarantee of Managing Director and also by a director of the company to the extent of amounts outstanding.

 

The average rate of interest is 12.00% p.a for Axis Bank (31 March 2015: 10.13% p.a) and 12.03% p.a. for Punjab National Bank (31 March 2015: 10.11% p.a).)

 

 

 

 

 

Total

256.557

315.975

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accountants

Address :

1-8-384 and 385, Gowra Grand, 3rd Floor, SP Road, Secunderabad - 500003, Telangana, India

PAN N Income-tax PAN of auditor or auditor's firm :

AACFD3771D

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiaries :

  • K.R.R. Drugs and Intermediates Private Limited, India

U24239AP2002PTC038417

 

 

KMP having significant influence (K.Subbarao)

  • Evertogen Life Sciences Limited (from 9 June 2016)

U24232TG2013PLC085349

 

  • GIL Agrotech (India) Private Limited, India

U01119TG2010PTC069551

 

 

Enterprise in which relatives of KMP can exercise significant Influence :

  • Northway Advisors LLP

 

 

Others :

  • ACINO Pharma AG, Switzerland

 

CAPITAL STRUCTURE

 

As on 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5000000

Equity Shares

INR 10/- each

INR 50.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3629080

Equity Shares

INR 10/- each

INR 36.291 Million

 

 

 

 

 

 

 

 

 

 

 

                                                                   


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET - STANDALONE

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

36.291

36.291

36.291

(b) Reserves and Surplus

865.844

726.562

661.136

(c) Money received against share warrants

0.000

0.000

0.000

(d) Minority interest

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

902.135

762.853

697.427

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

24.228

81.341

102.170

(b) Deferred tax liabilities (Net)

21.070

25.175

33.955

(c) Other long-term liabilities

0.000

67.120

123.390

(d) long-term provisions

8.610

17.040

4.906

Total Non-current Liabilities (3)

53.908

190.676

264.421

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

232.329

234.634

163.343

(b) Trade payables

248.820

273.382

184.203

(c) Other current liabilities

117.112

160.865

227.239

(d) Short-term provisions

60.068

42.842

17.600

Total Current Liabilities (4)

658.329

711.723

592.385

 

 

 

 

TOTAL

1614.372

1665.252

1554.233

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

385.018

385.183

374.671

(ii) Intangible Assets

2.544

2.213

2.012

(iii) Tangible assets capital work-in-progress

37.332

47.245

33.133

(iv) Intangible assets under development

0.000

0.000

28.116

(b) Non-current Investments

341.612

323.996

199.999

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

13.395

8.946

27.617

(e) Other Non-current assets

0.000

15.000

86.604

Total Non-Current Assets

779.901

782.583

752.152

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

51.367

(b) Inventories

309.450

422.989

268.636

(c) Trade receivables

340.773

251.704

158.041

(d) Cash and bank balances

5.532

8.990

65.281

(e) Short-term loans and advances

78.687

67.920

69.889

(f) Other current assets

100.029

131.066

188.867

Total Current Assets

834.471

882.669

802.081

 

 

 

 

TOTAL

1614.372

1665.252

1554.233

 

 

PROFIT & LOSS ACCOUNT - STANDALONE

 

 

PARTICULARS

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

Total Revenue from operations

1266.169

914.024

652.603

 

Other Income

93.446

29.171

24.705

 

TOTAL

1359.615

943.195

677.308

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

458.980

469.364

365.440

 

Purchases of Stock-in-Trade

83.398

4.805

14.850

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

61.336

(108.146)

(110.289)

 

Employee benefit expense

149.018

138.193

113.028

 

CSR expenditure

0.083

0.950

0.000

 

Other expenses

336.762

273.392

296.466

 

Exceptional items before tax

(52.650)

0.159

(376.049)

 

TOTAL

1036.927

778.717

303.446

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

322.688

164.478

373.862

 

 

 

 

 

Less

FINANCIAL EXPENSES

55.552

50.512

27.847

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

267.136

113.966

346.015

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

52.580

44.242

38.193

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

214.556

69.724

307.822

 

 

 

 

 

Less

TAX

78.383

33.256

102.393

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

136.173

36.468

205.429

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

476.290

406.530

301.920

 

TOTAL EARNINGS

476.290

406.530

301.920

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

57.730

76.270

64.880

 

Capital Equipment

10.760

4.160

1.580

 

TOTAL IMPORTS

68.490

80.430

66.460

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

37.52

10.05

56.61

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

57.522

63.992

63.430

Net cash flows from (used in) operations

204.638

(73.204)

(196.825)

Net cash flows from (used in) operating activities

140.072

(77.612)

(263.984)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

98.24

100.51

88.39

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.72

3.63

4.13

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

167.45

210.44

176.80

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.04

0.39

1.39

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.76

0.38

0.85

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.46

0.51

0.49

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.35

0.50

0.47

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.73

0.93

0.85

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.47

0.57

0.63

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

5.81

3.26

13.43

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

10.75

3.99

31.48

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

8.44

2.19

13.22

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

15.09

4.78

29.46

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

1.27

1.24

1.35

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.80

0.65

0.90

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.56

0.46

0.45

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

8.65

10.47

9.06

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.27

1.24

1.35

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

36.291

36.291

36.291

Reserves & Surplus

661.136

726.562

865.844

Net worth

697.427

762.853

902.135

 

 

 

 

Long-term borrowings

102.170

81.341

24.228

Short term borrowings

163.343

234.634

232.329

Current maturities of long-term debts

63.430

63.992

57.522

Total borrowings

328.943

379.967

314.079

Debt/Equity ratio

0.472

0.498

0.348

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

652.603

914.024

1266.169

 

0.000

40.058

38.527

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

652.603

914.024

1266.169

Profit/ (Loss)

205.429

36.468

136.173

 

31.48 %

3.99 %

10.75 %

 

 

 

ABRIDGED BALANCE SHEET – (CONSOLIDATED)

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

36.291

36.291

(b) Reserves & Surplus

 

864.828

709.421

(c) minority interest

 

6.627

296.227

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

907.746

1041.939

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

24.228

322.270

(b) Deferred tax liabilities (Net)

 

21.070

43.412

(c) Other long term liabilities

 

0.000

67.120

(d) long-term provisions

 

8.610

18.692

Total Non-current Liabilities (3)

 

53.908

451.494

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

232.329

255.685

(b) Trade payables

 

248.869

297.077

(c) Other current liabilities

 

118.751

245.398

(d) Short-term provisions

 

60.068

42.940

Total Current Liabilities (4)

 

660.017

841.100

 

 

 

 

TOTAL

 

1621.671

2334.533

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

385.018

1169.415

(ii) Intangible Assets

 

2.544

5.117

(iii) Capital work-in-progress

 

50.763

52.965

(iv) Intangible assets under development

 

0.000

105.733

(b) Non-current Investments

 

326.912

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

34.147

20.725

(e) Other Non-current assets

 

8.296

17.373

Total Non-Current Assets

 

807.680

1371.328

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

309.450

511.563

(c) Trade receivables

 

340.773

264.893

(d) Cash and cash equivalents

 

5.714

9.699

(e) Short-term loans and advances

 

59.004

73.555

(f) Other current assets

 

99.050

103.495

Total Current Assets

 

813.991

963.205

 

 

 

 

TOTAL

 

1621.671

2334.533

 

 

PROFIT & LOSS ACCOUNT– (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

 

1266.169

975.880

 

Other Income

 

92.467

32.227

 

TOTAL

 

1358.636

1008.107

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

458.980

496.963

 

Purchases of Stock-in-Trade

 

83.398

4.805

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

61.336

(164.481)

 

Employees benefits expense

 

149.018

167.196

 

CSR expenditure

 

0.083

0.950

 

Exceptional items

 

(76.574)

0.160

 

Other expenses

 

336.836

319.091

 

TOTAL

 

1013.077

824.684

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

345.559

183.423

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

55.552

61.663

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

290.007

121.760

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

52.580

69.478

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

237.427

52.282

 

 

 

 

 

Less

TAX

 

78.383

51.491

 

 

 

 

 

 

TOTAL PROFIT (LOSS) FOR PERIOD FROM CONTINUING OPERATIONS

 

159.044

0.791

 

 

 

 

 

Profit (loss) of minority interest

 

0.038

16.311

 

 

 

 

 

 

TOTAL PROFIT (LOSS) FOR PERIOD

 

159.082

17.102

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

43.84

4.71

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

 

17

Details of sister concerns

No

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

35

Negative Reporting by Auditors in the Annual Report

No

 

 

NOTE: Registered office of the company has been shifted from 120 Bhanu Enclave, Sundar Nagar, ESI, Hyderabad – 500038, Telangana, India to the present address w.e.f. 03.06.2006.

 

 

FINANCE

 

Cash and Cash equivalents as at the 31st March, 2016 was Rs. 5,531,000. The company continues to focus on the working capital parameters with strict check through continuous monitoring and does judicious management of its working capital, receivables and inventories.

 

COMPANY’s WORKING DURING THE CURRENT YEAR 2015-16 AND THE FUTURE PROSPECTS ALONG WITH REASONS WHILE COMPARING WITH PREVIOUS YEAR RESULTS

 

Performance of the Company for the year 2015-16 The Company has achieved a turnover of INR 1338.535 Million for the year ended 31St March 2016 compared to the previous year’s turnover of INR 964.569 Million representing a growth of 38.77%. The Company has earned an EBITDA of INR 322.688 Million for the year as compared to an EBITDA of INR 164.478 for the previous year. During the year the Company has got the renewal of GMP for Vizag Unit successfully. Outlook for the current year 206-17.

 

 

Bollarum Operations:

 

Company continues to increase its market share for the two products namely Amlodipine and Cetirizine to the existing and new customers/markets. Optimization of the capacities and productivity of these two products currently being manufactured by the Company at Bollaram, is ongoing and we expect to achieve the optimum capacities and productivities of these two products at Bollaram by the end of the financial year 16-17. Required capital investments to achieve this objective are on. In the meanwhile, Bollaram is operating at full capacity and will be able to achieve at least 20% higher output over the previous year. The company is ensuring that all the orders from the existing and new customers are being serviced to the best possible extent and the company is also able to achieve optimum prices. As a result, the company expects to achieve a higher, by at least 20 %, turnover and increased margins from the Bollaram operations during the year.

 

Vizag Operations:

 

The Company has sold the vizag facility to Torrent Pharmaceuticals during the year and handed over the facility to them on 3rd September 2016. The company has been able to achieve a turnover of about INR 235.000 Million for the 5 months ending August from the Vizag operations. As part of the BTA signed with Torrent, Torrent pharma agreed to execute the pending orders on the date of handing over and the company expects to achieve an additional turnover of about INR 110.000 Million from Vizag operations from 1st September, manufactured by Torrent from Vizag facility.

 

 

 

 

INDEX OF CHARGES:

 

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G35248921

90116056

PUNJAB NATIONAL BANK(on behalf of CONSORTIUM of PNB & Axis Bank Ltd)

24/01/2001

31/10/2016

-

285000000.0

Hi-Tech City Branch,1Q4-A3, 1st Floor, Cyber TowerMadhapurHyderabadTG500081IN

2

G46228789

10357060

PUNJAB NATIONAL BANK (on behalf of PNB CONSORTIUM where PNB & Axis Bank Ltd are members)

30/04/2012

04/10/2013

19/05/2017

243800000.0

Hi-Tec.City Branch, 1Q4-A3,1st Floor,Cyber TowersMadhapurHyderabadAP500081IN

3

G46228110

10563352

PUNJAB NATIONAL BANK

23/03/2015

-

19/05/2017

13000000.0

Hi-Tec.City Branch, 1Q4-A3,1st Floor,Cyber TowersMadhapurHyderabadTG500081IN

4

B95126868

90259724

Axis Bank Limited

06/08/1996

27/07/2013

31/01/2014

253000000.0

Ground & Ist Floor,6-3-879/B,G.Pullareddy BuildingGreenlands,Begumpet Road,HyderabadAP500016IN

5

B95078309

90115356

UTI BANK LIMITED

06/08/1996

29/12/2003

31/01/2014

6000000.0

BEGUMPETHAYDERABADAPIN

6

B91346072

10396629

Punjab National bank

13/12/2012

-

28/11/2013

13000000.0

HI-TECH.CITY BRANCH, 1Q4-A3,1ST FLOOR,CYBER TOWERSMADHAPURHYDERABADAP500081IN

7

B91911362

90119034

PUNJAB NATIONAL BANK

24/01/2001

15/12/2002

28/11/2013

7600000.0

1Q4 A3; CYBER TOWERSHITECH CITY; MADHAPURHAYDERABADAP500013IN

8

B83339077

90117886

UTI BANK LIMITED

29/12/2003

-

29/08/2013

7500000.0

BEGUMPETHAYDERABADAPIN

9

B83428896

10035995

AXIS BANK LIMITED

03/01/2007

29/05/2009

29/08/2013

47500000.0

6-3-879/B, GREENLANDS ROAD,BEGUMPET,HYDERABADAP500016IN

10

Y10210280

90117475

ANDHRA BANK

03/06/1999

-

17/04/2000

6000000.0

RAMACHANDRAPURAM BRANCHMEDAK DISTRICTMEDAKAP502032IN

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Office building
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles
  • Office equipment
  • Computer equipments

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.38

UK Pound

1

INR 86.02

Euro

1

INR 76.50

 

 

INFORMATION DETAILS

 

Information Gathered by :

PNM

 

 

Analysis Done by :

PRS

 

 

Report Prepared by :

SUJ


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.